WebCangrelor là một chất tương tự adenosine triphosphate tiêm tĩnh mạch (không phải thienopyridine) ức chế thụ thể P2Y12 adenosine diphosphate. ... Trong hai thử nghiệm đầu tiên là CHAMPION PLATFORM và CHAMPION PCI đánh giá cangrelor ở những bệnh nhân can thiệp mạch vành qua da đều không thấy ... WebSep 1, 2024 · Heterogeneity among the CHAMPION PCI, CHAMPION PLATFORM, and CHAMPION PHOENIX trials was evaluated using the Breslow-Day test. Baseline characteristics were summarized according to PAD history and treatment, cangrelor vs. clopidogrel; and were analyzed using analysis of variance for continuous variables and …
cangrelor - UpToDate
WebThe phase 3 CHAMPION clinical trial program of the investigational agent cangrelor was discontinued today. The intravenous agent was being evaluated in patients undergoing percutaneous coronary intervention (PCI). The announcement was made by the sponsoring company, The Medicines Company, in a press release. WebJun 4, 2016 · In CHAMPION-PLATFORM, patients were randomized to receive cangrelor bolus of 30 µg/kg and infusion 4 µg/kg/min or a matching placebo bolus and infusion. Patients in the placebo group received a … ethernet adapter keeps disconnecting
替格瑞洛的ChampionPhoenixIII期临床试验结果 - 豆丁网
WebThe DC/AC ratio or inverter load ratio is calculated by dividing the array capacity (kW DC) over the inverter capacity (kW AC). For example, a 150-kW solar array with an 125-kW … WebSep 3, 2013 · This prespecified, pooled analysis of patient-level data from three trials (CHAMPION-PCI, CHAMPION-PLATFORM, and CHAMPION-PHOENIX) compared cangrelor with control (clopidogrel or placebo) for … WebApr 9, 2024 · The CHAMPION-PLATFORM trial enrolled 5362 patients with stable angina, unstable angina or NSTE-ACS undergoing PCI . Patients were randomized to either cangrelor or placebo, bolus and infusion initiated during PCI, followed by 600 mg of clopidogrel at the end of the cangrelor infusion or at the end of the PCI for the placebo … ethernet adapter keeps turning on and off